REQUEST A DEMO
Total
USD $0.00
Search more companies

SCI Pharmtech, Inc. (旭富制药科技股份有限公司) (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: SCI Pharmtech, Inc. Profile Updated: January 14, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

SCI Pharmtech, Inc. (旭富制药科技股份有限公司) is based in Taiwan, China, with the head office in Taoyuan City. It operates in the Pharmaceutical and Medicine Manufacturing sector. The enterprise was incorporated on September 18, 1987. SCI Pharmtech, Inc. (旭富制药科技股份有限公司) currently employs 101 - 500 (2025) people. The company’s latest financial report indicates a net sales revenue drop of 11.91% in Q3C2025. Its’ total assets recorded a negative growth of 5.2%. The net profit margin of SCI Pharmtech, Inc. (旭富制药科技股份有限公司) decreased by 36.55% in 2025.

Headquarters
No.61, Ln. 309, Haihu N. Rd., Luzhu Dist
Taoyuan City; Taoyuan City;

Contact Details: Purchase the SCI Pharmtech, Inc. (旭富制药科技股份有限公司) report to view the information.

Website: http://www.sci-pharmtech.com.tw

Basic Information
Total Employees:
Purchase the SCI Pharmtech, Inc. (旭富制药科技股份有限公司) report to view the information.
Outstanding Shares:
Purchase the SCI Pharmtech, Inc. (旭富制药科技股份有限公司) report to view the information.
Financial Auditors:
Purchase the SCI Pharmtech, Inc. (旭富制药科技股份有限公司) report to view the information.
Incorporation Date:
September 18, 1987
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
29.78%
Purchase this report to view the information.
4.46%
Purchase this report to view the information.
2.82%
Purchase this report to view the information.
2.38%
Purchase this report to view the information.
1.23%
Subsidiaries
新高製藥股份有限公司
100%
Energenesis Biomedical CO.,Ltd.
2.03%
Company Performance
Financial values in the chart are available after SCI Pharmtech, Inc. (旭富制药科技股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-11.91%
Total Operating Revenue
-37.71%
Operating Profit
-84.14%
EBITDA
-62.91%
Net Profit/Loss for the Period
-85.96%
Total Assets
-5.2%
Total Equity
-0.92%
Operating Profit Margin
-42.36%
Net Profit Margin
-36.55%
Return on Equity (ROE)
-7.72%
Debt / Equity
-2.64%
Quick Ratio
-1.3%
Cash Ratio
-0.5%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?